Health

Results: 109-120 of 9174

Medisca Enters Its Next Chapter Under Founder Antonio Dos Santos

Nitinotes Expands European Commercial Adoption with First Commercial EndoZip™ Cases Performed in France

PR Newswire associated0

TrilliumBiO and The LAM Foundation Partner to Advance LAM Awareness and Education

New PROSPER Data Demonstrate Real-World Impact of Mogamulizumab on Symptoms and Health-Related Quality of Life in Mycosis Fungoides and Sézary Syndrome

Rachel Nordberg, PhD, from the DELTAi Lab at UC Irvine, prepping the BioServe device before it goes into orbit.

Cartilage Tissue Engineering Heads to Orbit in NSF and NASA-supported Study at the International Space Station

Business Wire embedded0

Court Clears Biocytogen’s RenNano® in Landmark Patent Dispute Against Harbour

Smartee Highlights Mandibular Repositioning Technology and Sleep Aligner Solutions at EOS 2026

Samsung Bioepis Announces Positive Preliminary Phase 1 and Phase 3 Data for SB27, a Proposed Biosimilar to Keytruda (Pembrolizumab)

AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia Areata

Zambon Announces Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations

AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Non-segmental Vitiligo

Enhertu® Approved in the EU as First Tumor Agnostic HER2 Directed Therapy and Antibody Drug Conjugate for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors